Nippon Kayaku Co (4272) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
3 Aug, 2026Executive summary
Net sales for Q1 FY2027 reached a record high of ¥67,402 million, up 23.1% year-over-year, with all major business units—Mobility & Imaging, Fine Chemicals, and Life Science—reporting significant sales and profit growth.
Operating income increased to ¥8.9 billion (+32.5% YoY), and profit attributable to owners of parent grew 41.7% to ¥6,081 million, driven by gains on investment security sales.
Comprehensive income more than doubled to ¥11,549 million, up 125.9% year-over-year.
Upward revisions were made to 1H and full-year forecasts due to strong performance and favorable exchange rates.
Financial highlights
Net sales: ¥67,402 million (+¥12.6 billion YoY); operating income: ¥8.9 billion (+¥2.2 billion YoY); profit attributable to owners: ¥6,081 million (+¥1.8 billion YoY).
Ordinary income rose to ¥7,390 million (+81.7% YoY); EPS increased to ¥41.08 (+50.5% YoY).
Gross profit increased to ¥20,914 million from ¥16,566 million YoY.
Total assets rose to ¥419,884 million, with net assets at ¥283,669 million and an equity ratio of 67.3%.
Non-operating and extraordinary income contributed positively, including ¥1.7 billion from investment security sales.
Outlook and guidance
1H FY2026 net sales forecast revised up by ¥10.3 billion to ¥133.8 billion; operating income up by ¥1.9 billion to ¥18.5 billion.
FY2027 full-year net sales forecast raised to ¥270,900 million (+12.0% YoY); operating income to ¥27,300 million (+21.6% YoY); profit to ¥22,900 million.
EPS for the full year forecast at ¥158.66; dividend forecast maintained at ¥66.00 per share.
ROE projected at 8.4% (previously 8.2%), ROIC at 6.0% (previously 5.6%).
Latest events from Nippon Kayaku Co
- Targets 500 bn yen sales and 15%+ ROE by 2035, driven by innovation and global leadership.4272
Investor presentation17 Jul 2026 - Record sales and profit growth, with continued sales gains and strong shareholder returns forecast.4272
Q4 202613 May 2026 - Profit attributable to owners of parent rose 30.1% on 4.0% sales growth, outlook steady.4272
Q3 20262 Feb 2026 - Net sales up 4.1% and profit nearly doubled on investment gains despite cost pressures.4272
Q2 202612 Nov 2025 - Strong sales and profit growth driven by Mobility & Imaging and Fine Chemicals; outlook revised up.4272
Q1 202519 Aug 2025 - Sharp profit growth and raised forecasts driven by Mobility & Imaging and Fine Chemicals.4272
Q3 202519 Aug 2025 - Sales and operating income surged, with upward guidance and major treasury stock buybacks.4272
Q2 202519 Aug 2025 - Record profit and strong segment growth; FY 2026 sees sales up, profit slightly down.4272
Q4 202519 Aug 2025 - Sales rose but profits fell amid higher costs and global risks; outlook remains cautious.4272
Q1 202619 Aug 2025